Journal article
As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
Abstract
BACKGROUND: Patients with mild asthma often rely on inhaled short-acting β2-agonists for symptom relief and have poor adherence to maintenance therapy. Another approach might be for patients to receive a fast-acting reliever plus an inhaled glucocorticoid component on an as-needed basis to address symptoms and exacerbation risk.
METHODS: We conducted a 52-week, double-blind, multicenter trial involving patients 12 years of age or older who had …
Authors
Bateman ED; Reddel HK; O'Byrne PM; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Siwek-Posluszna A; FitzGerald JM
Journal
The New England Journal of Medicine, Vol. 378, No. 20, pp. 1877–1887
Publisher
Massachusetts Medical Society
Publication Date
May 17, 2018
DOI
10.1056/nejmoa1715275
ISSN
0028-4793
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, InhalationAdolescentAdultAgedAged, 80 and overAsthmaBronchodilator AgentsBudesonideChildDouble-Blind MethodDrug Administration ScheduleDrug CombinationsFemaleForced Expiratory VolumeFormoterol FumarateGlucocorticoidsHumansMaintenance ChemotherapyMaleMedication AdherenceMiddle AgedProportional Hazards ModelsSeverity of Illness IndexSurveys and QuestionnairesTerbutalineYoung Adult